23 May 2013
Keywords: biogen, looking, bring, additional, drugs, market, back
Article | 03 June 1999
Having celebrated its 20th anniversary, US biotechnology firm Biogen isnow looking to build on the success of its multiple sclerosis ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 June 1999
4 June 1999
2 June 1999
© 2013 thepharmaletter.com